Hey everyone, A thought crossed my mind today and I thought I might try to get an outside perspective. Correct me if I am wrong but I feel that with respect to global vaccine rollouts we have simultaneously: a) A supply bottleneck preventing most countries from consistently accessing vaccine doses. C.f. current grandstanding between EU and UK around supply of the AZ vaccine. b) Opposition from many countries to proposals at the WTO level to waive aspects of IP relating to vaccine production. Currently however I see no discussion of how these two situations are incongruent. The supply issues mean that the obvious narrative of rich countries importing all the vaccines and exporting only "fuck you" is only partially valid as, under the current circumstances, they can't even procure enough for themselves. So why the reluctance to open up the IP and allow generic production (as with HIV antiretrovirals) which would presumably increase availability? I scanned through a few of these but I wanted to throw it out there before seeing if I have time later: